Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
test decrease » teer decrease (Expand Search), cost decreased (Expand Search), step decrease (Expand Search)
Showing 1,841 - 1,860 results of 15,626 for search '(( significance ((test decrease) OR (mean decrease)) ) OR ( significant increase decrease ))', query time: 0.38s Refine Results
  1. 1841
    Obese <i>mMgat2</i> and <i>HuMgat2</i> mice show defects in solute transporter protein levels.

    Obese <i>mMgat2</i> and <i>HuMgat2</i> mice show defects in solute transporter protein levels. by J. Jose Corbalan (22439198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1842
    Transcriptome and Metabolome Based Mechanisms Revealing the Accumulation and Transformation of Sugars and Fats in Pinus armandii Seed Kernels during the Harvesting Period

    Transcriptome and Metabolome Based Mechanisms Revealing the Accumulation and Transformation of Sugars and Fats in Pinus armandii Seed Kernels during the Harvesting Period by Nan Li (155066)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 1843
    Under steatotic conditions, primary <i>mMgat2</i> and <i>HuMgat2</i> hepatocytes induce apoptosis.

    Under steatotic conditions, primary <i>mMgat2</i> and <i>HuMgat2</i> hepatocytes induce apoptosis. by J. Jose Corbalan (22439198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1844
    Obese <i>HuMgat2</i> mice show defects in cytochrome P450 protein levels.

    Obese <i>HuMgat2</i> mice show defects in cytochrome P450 protein levels. by J. Jose Corbalan (22439198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1845
    Tgfβ-1 levels drives liver collagen deposition and pJak2-pStat3 signaling in obese <i>mMgat2</i> and <i>HuMgat2</i> mice.

    Tgfβ-1 levels drives liver collagen deposition and pJak2-pStat3 signaling in obese <i>mMgat2</i> and <i>HuMgat2</i> mice. by J. Jose Corbalan (22439198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1846
    Nuclear Srebp1 and Srebp2 protein levels and Srebp-dependent lipogenic gene expression are elevated in obese <i>mMgat2</i> and <i>HuMgat2</i> mice.

    Nuclear Srebp1 and Srebp2 protein levels and Srebp-dependent lipogenic gene expression are elevated in obese <i>mMgat2</i> and <i>HuMgat2</i> mice. by J. Jose Corbalan (22439198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1847
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1848
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1849
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1850
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1851
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1852
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1853
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1854
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1855
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1856
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1857
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1858
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1859
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1860
    Robustness test.

    Robustness test. by Jie Zhang (64655)

    Published 2024
    Save to List
    Saved in:

Search Tools: